Cancers 2010, 2(4), 1884-1894; doi:10.3390/cancers2041884
Review

Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer

1 Department of Research Oncology, Kings College London, 3rd Floor Bermondsey Wing, Guy’s Hospital, London, SE1 9RT, UK 2 Department of Medical Physics, Guys and St Thomas’ NHS Foundation Trust, 4th Floor Lambeth Wing, St Thomas’ Hospital, London, SE1 7EH, UK
* Author to whom correspondence should be addressed.
Received: 28 October 2010; in revised form: 2 November 2010 / Accepted: 9 November 2010 / Published: 17 November 2010
(This article belongs to the Special Issue Nanotechnology and Cancer Therapeutics)
PDF Full-text Download PDF Full-Text [228 KB, Updated Version, uploaded 3 December 2010 09:16 CET]
The original version is still available [288 KB, uploaded 17 November 2010 16:19 CET]
Abstract: The modern management of the axilla in breast cancer relies on surgery for accurate staging of disease and identifying those patients at risk who would benefit from adjuvant chemotherapy. The introduction of sentinel lymph node biopsy has revolutionized axillary surgery, but still involves a surgical procedure with associated morbidity in many patients with no axillary involvement. Nanotechnology encompasses a broad spectrum of scientific specialities, of which nanomedicine is one. The potential use of dual-purpose nanoprobes could enable imaging the axilla simultaneous identification and treatment of metastatic disease. Whilst most applications of nanomedicine are still largely in the laboratory phase, some potential applications are currently undergoing clinical evaluation for translation from the bench to the bedside. This is an exciting new area of research where scientific research may become a reality.
Keywords: axillary staging; breast cancer; nanoparticles; sentinel lymph node

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Johnson, L.; Charles-Edwards, G.; Douek, M. Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer. Cancers 2010, 2, 1884-1894.

AMA Style

Johnson L, Charles-Edwards G, Douek M. Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer. Cancers. 2010; 2(4):1884-1894.

Chicago/Turabian Style

Johnson, Laura; Charles-Edwards, Geoff; Douek, Michael. 2010. "Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer." Cancers 2, no. 4: 1884-1894.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert